Saphnelo (anifrolumab)

pCPA File Number: 22211

Negotiation Status:

Concluded with an LOI

Indication(s):

Systemic lupus erythematosus

Sponsor/Manufacturer:

AstraZeneca Canada Inc.

CDA-AMC Project Number:

SR0717

pCPA Engagement Letter Issued:

2023-04-24

Negotiation Process Concluded:

2023-10-25